The road to bringing a medical device to market is fraught with potential regulatory pitfalls and decisions that can delay—or even derail—your efforts.
Meet Sarah Cramer, Senior Director of Pathology Solutions at StageBio. Discover how specialized neuropathology expertise, advanced molecular techniques, and early collaboration help biotech clients de-risk programs and accelerate therapeutic development.
Date: October 21
Where: Cambridge, MA
Date: Nov 15-19
Location: San Diego, CA
Booth #504
Date: Nov 16-19
Location: Phoenix, AZ
Booth #616

Established by the merger of industry leaders, StageBio is an integrated partner serving the full spectrum of your histopathology needs. Our experienced team of laboratory staff, board-certified pathologists and archiving specialists are both experts in their respective fields and stewards of your projects’ success.

StageBio expands its capabilities on both sides of the Atlantic with the acquisition of TPL Path Labs.